---
figid: PMC9433080__cm9-135-1272-g001
pmcid: PMC9433080
image_filename: cm9-135-1272-g001.jpg
figure_link: /pmc/articles/PMC9433080/figure/F1/
number: Figure 1
figure_title: ''
caption: 'PI3K pathway and its role in the occurrence and development of NSCLC. AKT:
  Protein kinase B; BAD: Bcl-xL/Bcl-2 associated death promoter; CASP: Caspase; CHEK1:
  Checkpoint kinase 1; FOXO: Forkhead box O; GPCR: G protein-coupled receptor; GSK3:
  Glycogen synthesis kinase 3; HIF-1: Hypoxia-inducible factor 1; IκB: Inhibitor of
  nuclear factor kappa-B; IKK: Inhibitor of nuclear factor kappa-B kinase; MDM2: Murine
  double minute 2; mTORC: Mammalian target of rapamycin complex; NF-κB: Nuclear factor
  kappa-light chain enhancer of activated B cells; NO: Nitric oxide; NSCLC: Non-small
  cell lung cancer; P53: Protein 53; PDK1: Pyruvate dehydrogenase kinase 1; PI3K:
  Phosphosphatidylinositol-3-kinase; PIP2: Phosphatidylinositol 4,5-bisphosphate;
  PIP3: Phosphatidylinositol-3,4,5-triphosphate; PTEN: Phosphatase and tensin homolog;
  RHO: Ras homolog; RTKs: Receptor tyrosine kinases; TSC: Tuberous sclerosis complex;
  VEGF: Vascular endothelial growth factor.'
article_title: Treating non-small cell lung cancer by targeting the PI3K signaling
  pathway.
citation: Lin Jiang, et al. Chin Med J (Engl). 2022 Jun 5;135(11):1272-1284.
year: '2022'

doi: 10.1097/CM9.0000000000002195
journal_title: Chinese Medical Journal
journal_nlm_ta: Chin Med J (Engl)
publisher_name: Lippincott Williams & Wilkins

keywords:
- Phosphosphatidylinositol-3-kinase signaling pathway
- Protein kinase B
- Mammalian target of rapamycin
- Non-small cell lung cancer

---
